Page last updated: 2024-11-06

mitomycin and Afferent Pupillary Defect

mitomycin has been researched along with Afferent Pupillary Defect in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research Excerpts

ExcerptRelevanceReference
"We report a case of a rare complication after trabeculotomy combined with a small trabeculectomy with mitomycin C in a young patient with juvenile glaucoma."3.88Urrets-Zavalia Syndrome After Combined Trabeculotomy-Trabeculectomy Surgery. ( Gericke, A; Hoffmann, EM; Klezlova, A; Liebezeit, S; Pfeiffer, N; Prokosch-Willing, V, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klezlova, A1
Liebezeit, S1
Prokosch-Willing, V1
Gericke, A1
Pfeiffer, N1
Hoffmann, EM1

Other Studies

1 other study available for mitomycin and Afferent Pupillary Defect

ArticleYear
Urrets-Zavalia Syndrome After Combined Trabeculotomy-Trabeculectomy Surgery.
    Journal of glaucoma, 2018, Volume: 27, Issue:4

    Topics: Adult; Combined Modality Therapy; Glaucoma; Humans; Hydrophthalmos; Intraocular Pressure; Male; Mito

2018